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Tangier disease is an inherited disorder that results in a deficiency in circulating levels of HDL. Although the disease is known
to be caused by mutations in the ABCA1 gene, the mechanism by which lesions in the ABCA1 ATPase effect this outcome is not
known. The inability of ABCA1 knockout mice (ABCA1
2/2) to load cholesterol and phospholipids onto apoA1 led to a proposal
that ABCA1 mediates the transbilayer externalization of phospholipids, an activity integral not only to the formation of HDL
particles but also to another, distinct process: the recognition and clearance of apoptotic cells by macrophages. Expression of
phosphatidylserine (PS) on the surface of both macrophages and their apoptotic targets is required for efficient engulfment of
the apoptotic cells, and it has been proposed that ABCA1 is required for transbilayer externalization of PS to the surface of
both cell types. To determine whether ABCA1 is responsible for any of the catalytic activities known to control transbilayer
phospholipid movements, these activities were measured in cells from ABCA1
2/2 mice and from Tangier individuals as well as
ABCA1-expressing HeLa cells. Phospholipid movements in either normal or apoptotic lymphocytes or in macrophages were not
inhibited when cells from knockout and wildtype mice or immortalized cells from Tangier individuals vs normal individuals
were compared. Exposure of PS on the surface of normal thymocytes, apoptotic thymocytes and elicited peritoneal
macrophages from wildtype and knockout mice or B lymphocytes from normal and Tangier individuals, as measured by
annexin V binding, was also unchanged. No evidence was found of ABCA1-stimulated active PS export, and spontaneous PS
movement to the outer leaflet in the presence or absence of apoA1 was unaffected by the presence or absence of ABCA1.
Normal or Tangier B lymphocytes and macrophages were also identical in their ability to serve as targets or phagocytes,
respectively, in apoptotic cell clearance assays. No evidence was found to support the suggestion that ABCA1 is involved in
transport to the macrophage cell surface of annexins I and II, known to enhance phagocytosis of apoptotic cells. These results
show that mutations in ABCA1 do not measurably reduce the rate of transbilayer movements of phospholipids in either the
engulfing macrophage or the apoptotic target, thus discounting catalysis of transbilayer movements of phospholipids as the
mechanism by which ABCA1 facilitates loading of phospholipids and cholesterol onto apoA1.
Citation: Williamson P, Halleck MS, Malowitz J, Ng S, Fan X, et al (2007) Transbilayer Phospholipid Movements in ABCA1-Deficient Cells. PLoS ONE 2(8):
e729. doi:10.1371/journal.pone.0000729
INTRODUCTION
Mutations in the ATP-binding cassette (ABC) ATPase, ABCA1,
are responsible for Tangier disease [1–3], an autosomal recessive
disorder characterized by the virtual absence of high-density
lipoprotein (HDL), reduced levels of low-density lipoprotein
(LDL), and mildly elevated triglycerides. Mice in which the
ABCA1 gene has been disrupted (ABCA1
2/2) are unable to load
cholesterol and phospholipids to apoA-1, implicating ABCA1 in
the efflux of these lipids from cells [4–6]. Remarkably, mutations
in ABCA1 have been reported to give rise to a seemingly unrelated
phenotype, a defect in the clearance of apoptotic cells by
macrophages [7]. When cells undergo apoptosis or programmed
cell death, they must distinguish themselves from their healthy
counterparts in order to be safely eliminated. A number of
molecules on the apoptotic cell surface have been implicated as
ligands for a wide variety of receptors on the macrophage surface
[8,9]. However, ABCA1, a membrane-spanning enzyme that is
not an obvious candidate as either ligand or receptor, has been
identified as necessary for efficient engulfment of apoptotic cells.
When antibodies to this ATPase are introduced into macrophages,
their ability to engulf apoptotic thymocytes is severely compro-
mised [10].
The evidence for involvement of an ABC ATPase in the
recognition of mammalian apoptotic cells echoes findings from
genetic studies of cell death in the nematode, C. elegans.
Engulfment in C. elegans is controlled by a group of ced, or cell
death genes [11]. One of these genes, ced-7, encodes an ABC
protein [12]. Interestingly, efficient clearance of corpses requires
expression of ced-7 in both apoptotic germ cells and the gonadal
sheath cells that engulf them [12].
This curious requirement for the same factor at the surface of
both target and phagocyte is mirrored by another molecule.
Redistribution of phospholipids across the plasma membrane of
both apoptotic targets and phagocytes plays a crucial role in
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cally across the membrane bilayer, with the aminophospholipids,
phosphatidylserine (PS) and phosphatidylethanolamine (PE),
concentrated in the inner leaflet, and the neutral phospholipids,
phosphatidylcholine (PC) and sphingomyelin, concentrated in the
outer leaflet. This distribution is maintained by an aminopho-
spholipid translocase, a P-type ATPase [13] that actively and
specifically transports the aminophospholipids from the outer to
the inner leaflet of the bilayer [14]. When lymphocytes undergo
apoptosis, they inactivate this enzyme and activate a non-specific
lipid flipsite, termed the scramblase, which promotes rapid
equilibration of phospholipids across the bilayer, producing
a symmetric distribution [15]. When PS, which is normally
restricted to the inner leaflet of the plasma membrane, reaches
the surface of the cell, it serves as a recognition signal for
macrophage engulfment [8,16]. On the other hand, macro-
phages constitutively express low levels of PS on their surface
[17], which is acquired as monocytes differentiate into macro-
phages [18]. Interestingly, ABCA1 expression is upregulated
during monocyte/macrophage differentiation [19]. PS on both
the apoptotic lymphocyte and the macrophage is required for
phagocytosis of the apoptotic cell, since phagocytosis is inhibited
by masking the PS on either of the partner cells using the small
protein, annexin V, whose Ca
2+-dependent binding is PS-specific
[17,18,20].
The dual requirement for ced-7 and the dual requirement for
cell surface PS for apoptotic cell engulfment raise the possibility
that the two are related; in mammals, this hypothesis predicts
that ABCA1 plays a role in the exposure of PS on both the
apoptotic lymphocyte and the macrophage. Tests of this
hypothesis have been performed. The scramblase, responsible
for exposure of PS on apoptotic lymphocytes, can be artificially
activated in the absence of apoptosis by elevating cytosolic levels
of Ca
2+ using a Ca
2+ ionophore [21,22]. PS exposure by this
process in both lymphocytes and macrophages is inhibited by
glyburide or oligomycin, chemical inhibitors of ABC transporters
[23]. Furthermore, when either apoptotic lymphocytes or
macrophages are treated with the inhibitors, phagocytosis is
inhibited [23]. However, these experiments cannot prove that
ABCA1 is responsible for PS exposure. The inhibitors are not
specific to ABCA1 and their effects might result directly or
indirectly by inhibiting something else, including some other
ABC protein.
A more specific test for ABCA1 function is provided by cells
from ABCA1
2/2 mice and from Tangier patients homozygous for
mutations that disrupt expression of the human ABCA1 gene. One
study using ABCA1
2/2 mice reported a reduction in PS exposure
on the surface of red blood cells in which the scramblase had been
activated by Ca
2+ and on apoptotic lymphocytes as assessed by
annexin V binding [7]. Here, we examine the role of ABCA1 in
phospholipid externalization in detail, measuring a wide variety of
transbilayer movements in cells from ABCA1
2/2 mice and from
Tangier individuals as well as ABCA1-expressing HeLa cells,
including translocation of phospholipids across the plasma
membrane by the aminophospholipid translocase, both spontane-
ous (basal) and scramblase-mediated movement of PS from the
inner to the outer leaflet of the plasma membrane, and the steady-
state exposure of PS on the cell surface. In addition, we test the
ability of ABCA1-deficient macrophages to phagocytose apoptotic
cells and the ability of ABCA1-deficient apoptotic lymphocytes to
serve as targets for macrophages. Finally, we test the hypothesis
that ABCA1 is required for exposure of annexins on the
macrophage surface, proteins previously shown to be involved in
phagocytosis of apoptotic lymphocytes [24].
RESULTS
The distribution of phospholipids across the plasma membrane is
regulated by at least two opposing activities. One is active
transport of PS, and to a lesser extent PE, from the outer to the
inner leaflet by the aminophospholipid translocase; the other is
equilibration of all phospholipids between the inner and outer
leaflets by the scramblase. ABCA1 could affect phospholipid
externalization if it were one of these two enzymes, if it regulated
one of these activities, or if it supplemented these activities. These
possibilities are outlined in Figure 1, and systematically in-
vestigated below.
Translocase Activity
In healthy normal cells, the aminophospholipid translocase activity
rapidly transports PS from the outer to the inner leaflet of the
plasma membrane bilayer, in contrast to the slower, unaided
diffusion of PC across the same bilayer. In apoptotic cells this
activity is down-regulated. ABCA1 might contribute to PS
exposure on the cell surface if it reduced or blocked translocase
activity. If so, ABCA1 mutations would be expected enhance
translocase activity in healthy cells, or to no longer allow the
translocase to be inactivated in apoptotic cells. To measure
translocase activity, fluorescent NBD-PS or NBD-PC derivatives
are introduced into the outer leaflet of cells, and the kinetics of
probe transfer to the inner leaflet measured periodically by first
removing probe still on the surface with BSA-containing buffers
and then quantitating the remaining, internalized probe by
measuring cellular fluorescence using flow cytometry. Figure 2A
shows the results of applying this assay to primary fibroblasts from
normal and Tangier individuals. Internalization of PC was slow
for both normal and mutant nonapoptotic cells. This rate provides
an upper boundary for probe internalization by endocytosis,
although measurements of internalization of other probes such as
sphingomyelin (not shown) indicate that PC internalization
overestimates the contribution of endocytosis. In contrast, in-
ternalization of PS was rapid in both normal and Tangier cells,
indicating that disabling the ABCA1 gene does not enhance PS
internalization by the aminophopholipid translocase in these cells.
Similar results were observed in comparisons of translocase activity
in normal vs Tangier EBV-transformed B lymphocytes, in
thymocytes from wildtype vs ABCA1
2/2 mice, and in control
human HeLa cells, which do not express detectable levels of
ABCA1 protein, or transfected HeLa cells expressing functional
ABCA1 protein [25](data not shown).. These results show that
ABCA1 is not the aminophospholipid translocase, and suggest that
it is also not a negative regulator of the translocase, since its
absence does not enhance and its overexpression does not reduce
translocase activity (see Table 1 for a summary of these and
following results). These results leave open the possibility that
ABCA1 is required to downregulate the translocase in apoptotic
cells. In apoptotic cells, not only translocase activity but also
transbilayer lipid movements catalyzed by the scramblase must be
considered in PS externalization. Therefore, whether ABCA1 is or
regulates the scramblase was addressed.
Ca
2+-activated Scramblase Activity
Normally, the basal level of movement of PS from the inner to the
outer leaflet of the plasma membrane, is slow; activation of the
scramblase enhances the rate of PS externalization. When Ca
2+
and a Ca
2-ionophore are added to normal human or mouse
lymphocytes at levels that result in elevation of cytosolic Ca
2+
concentrations within a few seconds, scramblase-mediated lipid
movement begins after a lag of a minute or more [22]. Net PS
ABCA1 in Phospholipid Dynamics
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labeled annexin V; in the presence of this probe, PS appearance
on the cell surface results in binding of annexin V and an increase
in cellular fluorescence which can be measured in the flow
cytometer continuously as a function of time. This assay was used
to demonstrate that extensive exposure of thymocytes to glyburide,
an inhibitor of ABC proteins, prevents exposure of PS on the cell
surface when cytosolic Ca
2+ concentrations are elevated [23].
Glyburide could inhibit PS exposure by blocking some step in the
lag phase, and thereby prolonging the onset of lipid movement
indefinitely, or by blocking lipid movement itself, after completion
of steps in the lag phase. To distinguish these possibilities, 50 mM
Figure 2. Internalization (translocation) of NBD-labeled phospholipids by normal human fibroblasts and fibroblasts from Tangier individuals.
The outer leaflet of the plasma membrane of normal (circles) or Tangier (squares) fibroblasts was labeled with NBD-PC (open symbols) or NBD-PS
(filled symbols). At various times samples were removed into BSA to extract outer leaflet probe and remaining inner leaflet probe was measured by
flow cytometry and expressed as percent transported. Measurements were made at room temperature. (A) Viable fibroblasts, (B) spontaneously
apoptotic fibroblasts. Dashed and dotted lines in B have been redrawn from A for transport by normal fibroblasts.
doi:10.1371/journal.pone.0000729.g002
Figure 1. Known and potential transbilayer lipid transporters. The aminophospholipid translocase (left) and ABCA1 (right) proteins are drawn
approximately to scale in outline forms taken from atomic structures of a P-type ATPase (the Ca
2+ transporter;[54]) and an ABC protein (BtuCD,[55]).
The molecular shape of the scramblase (center) is arbitrary, since the protein responsible for this activity is not known. One possibility, investigated
here, is that the ABCA1 protein is actually the protein responsible for this activity; another possibility is that the ABCA1 protein transports PS from the
inner to the outer leaflet, as depicted. An HDL particle (far right) is also drawn approximately to scale by extrapolation from the structure of other
lipoprotein particles, with the apoA1 protein drawn as the belt-like helices enclosing the lipid core. The molecular shape of an unlipidated apoA1
protein is unknown.
doi:10.1371/journal.pone.0000729.g001
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suspension culture; at intervals, aliquots were removed and the
ability of the cells to activate the scramblase was tested by
measuring PS exposure after addition of Ca
2+ and ionophore. At
a concentration of 50 mM, glyburide inhibition of scramblase
activity was complete by 30 min after addition of the inhibitor to
cells (data not shown). At earlier times during this incubation,
inhibition was observable, but incomplete. When the kinetics of PS
exposure were examined at these intermediate times, it was
apparent that the lag time before the onset of lipid movement
remained relatively constant, but that once the lag was over, the
rate at which PS moves to the external leaflet was slowed (data not
shown). These results show that the effect of glyburide is not on the
preliminary step(s) that occur during the lag phase, but rather on
lipid movement itself, consistent with a role for an ABC protein in
the process of PS externalization. However, there are many
potential targets for glyburide which might account for its effects
on this process. A more definitive test of whether ABCA1 is
required for PS externalization is whether there is a detectable
inhibition of scramblase-mediated phospholipid movements in
ABCA1-deficient cells.
It has been reported that Ca
2+-induced externalization of PS is
inhibited in primary fibroblasts isolated from ABCA1
2/2 mice, as
measured by a reduced fraction of cells binding annexin V over
time compared to wildtype controls [7]. These data suggest that
ABCA1 is required for activation of scramblase activity. Indeed, as
shown in Figure 3A, no Ca
2+-activated PS externalization could be
detected in primary fibroblasts from Tangier individuals. Howev-
er, normal fibroblasts with a functional ABCA1 activity (as
indicated by lipid transfer to apoA1, not shown) also do not expose
PS in response to Ca
2+ (Figure 3A). This absence of Ca
2+
activation of scramblase activity was observed in a variety of
fibroblast and epithelial cell lines (CHO, BHK, 3T3, MCF-7,
HeLa) and other non-hematopoietic cell types (data not shown),
suggesting that the ability to activate the scramblase with Ca
2+ is
most developed in red blood cells, platelets, lymphocytes, and
macrophages. Since Ca
2+ does not activate scramblase activity in
HeLa cells and HeLa cells do not express detectable levels of
ABCA1 protein [25], it was asked whether expressing ABCA1 in
HeLa cells could produce Ca
2+-activated scrambling. However, no
activity was seen (data not shown), indicating that elevation of
ABCA1 expression does not repair the absence of Ca
2+_activated
PS externalization in either HeLa cells or fibroblasts.
The fact that ABCA1 alone is not sufficient to confer Ca
2+-
dependent scramblase activity does not rule out the possibility,
suggested by the studies with glyburide ([7] and see above), that it
is nevertheless required in those cells in which such activation
occurs. As shown in Figure 3B, Ca
2+-activated PS externalization
does occur in EBV-transformed human B lymphocytes (Figure 3B);
however, it also occurs at identical rates in EBV-transformed
human B lymphocytes from Tangier individuals. To ensure that
these results were not peculiar to the human system or to cultured
cell lines, similar experiments were carried out with primary
mouse cells. As shown in Figure 3C, PS externalization by Ca
2+-
activated scramblase activity proceeded at identical rates in
primary thymocytes from wildtype and ABCA1
2/2 mice, in-
dicating that human and murine lymphoid cells behave identically
in this respect. In the original report suggesting that Ca
2+ induced
exposure of PS was sensitive to ABCA1 deletion [7], although
a similar assay was used, the result was not reported as the level of
PS exposure, as shown here, but rather the fraction of cells in
which PS exposure was elevated. The latter measure is more
sensitive to changes in the efficiency of scramblase activation, and
less sensitive to changes in the rate of lipid movement. To ensure
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PLoS ONE | www.plosone.org 4 August 2007 | Issue 8 | e729that the difference in measures reported (fraction of PS-exposing
cells vs level of PS exposure) was not responsible for the difference
in results compared to the previous study, the fraction of PS-
exposing cells was determined. As shown in Figure 3D, the rate at
which cells become activated is not slower in cells from the
ABCA1
2/2 mice. In addition, the fraction of responsive cells is not
reduced; indeed, in the experiment shown this fraction was slightly
elevated in cells from the knockout mice, although in repeated
experiments, this result was not generally observed. Together,
these results demonstrate that deletion of ABCA1 does not reduce
the efficiency of scramblase activation, and does not reduce the
rate of PS movement catalyzed by the scramblase following
elevation of cytosolic Ca
2+ levels in either human or mouse cells.
Apoptosis-induced Scramblase Activity
Studies with cells from patients with Scott disease, in which Ca
2+
activation of the scramblase has been inactivated by mutation,
suggest that the scramblase activated during apoptosis may be the
same as the scramblase activated by elevated cytoplasmic Ca
2+,
but that the activation mechanisms are distinct [22]. If so, it is
possible that ABCA1 is only required for PS exposure during
apoptosis, which would explain the inability of ABCA1 deletion to
block Ca
2+-induced lipid movement in normal, healthy cells. The
activation of scramblase during apoptosis is most easily seen in the
change in NBD-PS and NBD-PC movement observed in
apoptotic cells. Apoptotic cells can be identified by their
characteristic light scattering properties (see Figure 4, below), so
that internalization of phospholipid by just those cells can be
measured using flow cytometry. In contrast to healthy cells where
the aminophospholipid translocase transports NBD-PS (but not
NBD-PC) rapidly to the inner leaflet (see Figure 2A), in apoptotic
fibroblasts, both phospholipids moved to the cell interior at the
same intermediate rate (Fig 2B). The same change in pattern, and
the same resulting rates of lipid movement, were observed whether
the fibroblasts were normal or Tangier apoptotic fibroblasts,
indicating that ABCA1 deletion does not inhibit this process.
Similar results were seen with EBV-transformed apoptotic normal
and Tangier B lymphocytes, as well as with apoptotic normal and
ABCA1-expressing HeLa cells (data not shown), indicating that
ABCA1 is not required for activation of the scramblase in
apoptotic cells, nor does it contribute positively or negatively to the
rate at which phospholipids move across the bilayer in apoptotic
lymphocytes or fibroblasts. In addition, the failure to observe
accumulation of PS in the interior of ABCA1-deficient apoptotic
Figure 3. Endogenous PS externalization in normal and ABCA1-deficient cells measured by continuous annexin V binding assay. (A) Normal or
Tangier human fibroblasts, (B) EBV-transformed normal or Tangier B lymphocytes, or (C and D) thymocytes from wildtype or ABCA1
2/2 mice were
treated with Ca
2+ and Ca
2+ ionophore, and cellular fluorescence in the presence of fluorescent annexin V measured continuously over time at room
temperature. Normal/wildtype, filled circles; ABCA1-deficient, open circles. A–C, median fluorescence of cells; D, fraction of cells stained by
fluorescent annexin.
doi:10.1371/journal.pone.0000729.g003
ABCA1 in Phospholipid Dynamics
PLoS ONE | www.plosone.org 5 August 2007 | Issue 8 | e729cells shows that the translocase has been inactivated as usual,
showing that ABCA1 is not required for down-regulation of the
translocase activity.
Although these data indicate that the scramblase is activated
during apoptosis in cells lacking ABCA1, it is possible that ABCA1
is still necessary for this activation to be efficient. Cells in
a population do not enter apoptosis synchronously; induction of
lipid movements is therefore not synchronous, as it is for Ca
2+-
activated induction. As a result, the efficiency of scramblase
induction during apoptosis cannot be measured by the continuous
annexin V binding assays described above. However, it is possible
to measure the rate of activation of PS exposure relative to other
events in the apoptotic program, using conventional annexin V
binding assays. Apoptotic cells undergo measurable cell shrinkage.
If PS exposure is induced before this change in size, annexin V
binding is observed in cells of normal size and shape, as well as in
the smaller and more irregularly shaped apoptotic cells produced
by shrinkage. This pattern can be readily detected in the flow
cytometer, as shown for EBV-transformed apoptotic B lympho-
cytes in the left panels of Figure 4(A,C,E,G). Cells in the gated R2
subpopulation are of normal size and shape, while cells which have
undergone shrinkage appear in the gated R1 subpopulation of
lower forward angle light scatter and slightly higher side scatter. At
early times after the induction of apoptosis, PS-exposing cells,
which are usually absent from the normal (R2) subpopulation
(Fig 4B), begin to appear (Fig 4D). If inactivation of ABCA1
substantially slowed the onset of lipid rearrangements, more cells
would be expected to complete the shrinkage step before the
activation of lipid movement. The result would be a substantial
drop in the number of PS-exposing cells in the subpopulation of
cells with normal morphology. As shown in Figure 4 (D compared
to H), this expectation is not observed; in fact in this example,
normal-sized cells which expose PS and bind annexin V appear at
a slightly higher frequency in the absence of ABCA1. These results
suggest that deletion of ABCA1 does not reduce the efficiency of
scramblase activation in apoptotic cells.
PS-specific Outward Lipid Movement
It has been suggested that ABCA1 contributes to PS exposure, not
through the scramblase, but rather by specific enhancement of
movement of just PS from the inner to the outer leaflet [26](see
Discussion). As shown in Figure 3, the presence or absence of
ABCA1 makes no detectable difference in the rate at which PS
externalization occurs in cells in which the scramblase is activated
by Ca
2+. It could be that the rate of externalization of PS induced
by Ca
2+ is too fast to see the effects of additional, ABCA1-
dependent, PS movement. One might, therefore, measure PS
externalization in cells in which the scramblase was not activated,
except that, as shown in Figure 2, ABCA1-dependent PS
movement to the external leaflet would be masked by the action
of the translocase. However, a method has been devised to
measure PS externalization rates irrespective of an active translo-
case. In this assay, healthy cells were allowed to internalize NBD-
PS by means of the translocase, and were then placed in the
presence of the reducing agent sodium dithionite. In the presence
of this reagent, internalized NBD-PS which reappears at the cell
surface is immediately reduced to a non-fluorescent amino
derivative. The resulting decrease in cell fluorescence with time
thus measures the rate at which the PS analog moves from the
inner leaflet to the cell surface. As shown in Figure 5, NBD-PS
moved from the cell interior to the cell surface in lymphocytes,
fibroblasts, or HeLa cells. These observed basal rates differ
significantly from one cell type to another, ranging from a half
time for externalization of about 8 min in B lymphocytes to about
2 min in HeLa cells; importantly, these times are all slow by
comparison with the half time for probe reduction by dithionite
(about 5 sec). These rates are not increased by increasing the
concentration of added dithionite (data not shown), indicating that
they are not the result of membrane permeability to dithionite.
There are no differences in the externalization rates between
normal and Tangier fibroblasts (Figure 5A) or B lymphocytes
(Fig 5B), or between normal and ABCA1-expressing HeLa cells
(Fig 5C), showing that the basal PS externalization process in all of
these cells is independent of ABCA1. Because ABCA1 has been
reported to directly bind apoA1 [27], the possibility was
considered that ABCA1 catalyzed lipid exchange only in response
to the presence of apoA1. As shown in Figure 5E and 5F, however,
the presence of apoA1 had no effect on the rate of PS
externalization, suggesting that apoA1 binding to ABCA1 does
not result in active PS externalization.
Because this assay measures phospholipid externalization
directly, versus indirectly by annexin V binding, it might be
considered a more valid assay for detecting active PS-specific
externalization. Although the assay cannot be applied to apoptotic
cells, since they are permeable to dithionite (unpublished
observation), it can be used to measure Ca
2+-induced PS
externalization. As shown in Figure 5D, the assay reveals that
a substantial rate of PS externalization takes place in primary
mouse thymocytes without scramblase activation; as in the case of
human lymphocytes and fibroblasts (Fig 5 A–C), the rate was
unaltered in ABCA1-deficient cells. Upon activation of scramblase
Figure 4. Endogenous PS externalization in apoptotic EBV-trans-
formed human B lymphocytes. EBV-transformed normal (A–D)o r
Tangier (E–H) B lymphocytes were untreated (A&B, E&F) or treated with
camptothecin (C&D, G&H) to induce apoptosis, stained with fluorescent
annexin V, and examined by flow cytometry. Left panel, forward (FS) vs
side (SS) light scatter plots, with cells of normal size and shape in the R2
gate and shrunken cells in the R1 gate. Right panel, fluorescence profile
of cells in the R2 gate.
doi:10.1371/journal.pone.0000729.g004
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2+, this rate increased as expected (Figure 5D).
Notably, however, the increase in the rate of PS externalization
was seen in both wild type and ABCA1-deficient cells, and the
increase was even greater in the mutant compared to normal cells.
These results indicate that ABCA1 does not contribute to any
measurable avenue of Ca
2+-activated PS externalization in these
cells.
ABCA1 Function in Macrophages
ABCA1 is present and active in macrophages [28], consistent with
a role for the protein in both cholesterol export and apoptotic cell
removal, since both of these functions are important in macro-
phages. It is thus possible that the role of ABCA1 in lipid
movements is specifically observable in macrophages. To in-
vestigate this possibility, elicited peritoneal macrophages from
wildtype and ABCA1
2/2 mice were examined. Although the
exudate cell population is quite heterogeneous, viable macro-
phages can be identified with mAb antibody F4/80[29]; F4/80-
positive cells occupy a discrete region, gated subpopulation M, in
the forward light scatter/side light scatter profile of the entire cell
population (Figure 6A and 6B). F4/80-negative cells are also
present, such as gated subpopulation S in Figure 6A and 6B. Cells
in both the M and S regions exclude propidium iodide, indicating
that they retain an intact plasma membrane.
The cells in the S subpopulation resemble most normal healthy
cells in that they fail to bind annexin V (data not shown), implying
that the lipids in the plasma membrane are asymmetric, with PS
Figure 5. Basal (or Ca
2+-activated) NBD-PS externalization in normal and ABCA1-deficient cells. (A) Normal human or Tangier fibroblasts, (B) EBV-
transformed normal or Tangier B lymphocytes, (C) Control or ABCA1-GFP-transfected HeLa cells, (D) thymocytes from wildtype or ABCA1
2/2 mice, (E)
normal human fibroblasts or (F) Tangier fibroblasts were allowed to internalize NBD-PS, dithionite added to reduce and render non-fluorescent
externalized NBD-PS, and cellular fluorescence (unexternalized NBD-PS) measured continuously over time at room temperature. (A–D) normal/
wildtype, filled symbols; ABCA1-deficient or replete (HeLa), open symbols. (D) untreated, circles; treated with Ca
2+ and Ca
2+ ionophore, squares. (E
and F) presence (open triangles) or absence (closed triangles) of apoA1.
doi:10.1371/journal.pone.0000729.g005
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of ABCA1 in HeLa cells results in a small, but measurable increase
in binding of annexin V to the surface of normal healthy cells,
suggesting that ABCA1 expression may result in low level PS
exposure in these cells [7]. This result is reminiscent of the
observation that the lipid distribution in the plasma membrane of
macrophages differs from that of most other normal healthy cells
in that PS is constitutively expressed at low levels on the surface of
viable, non-apoptotic macrophages, where it is required for
efficient recognition of PS-exposing apoptotic target cells [17].
We therefore asked whether this macrophage-specific PS exposure
was ABCA1-dependent. As shown in Figure 6C, macrophages in
the M region display this low level of Ca
2+-dependent annexin V
binding, consistent with the presence of low levels of PS exposed
on their surface. However, as shown in Figure 6D, Ca
2+-
dependent binding of annexin V is not reduced in macrophages
from ABCA1
2/2 mice, indicating that this characteristic is not
ABCA1-dependent. In view of these results, annexin V binding by
healthy HeLa cells expressing ABCA1 was examined and the data
confirmed that these cells do bind slightly more annexin V than
control HeLa cells. However, this binding was not Ca
2+-
dependent (data not shown). Since Ca
2+ dependence is the
hallmark of PS-specific annexin binding, this result does not reflect
increased PS exposure, and is therefore unrelated to constitutive
PS exposure in macrophages.
Annexin V binding by macrophages reveals the steady-state
presence of PS in the outer leaflet of the plasma membrane, but
provides no information on the transbilayer lipid movements that
underlie this distribution. Measuring these movements with NBD-
labeled phospholipids as was done above with other cell types can
be problematic with macrophages, which rapidly internalize
membrane by endocytosis. This rapid bulk membrane flow
nonspecifically internalizes any lipid probe present in the
membrane, sequestering even externally-directed probes in the
lumenal leaflet of a vesicle. This process does not require, and can
even mask, transbilayer lipid transport. Sodium dithionite was
used to overcome this problem. After addition of NBD-labeled
lipids and incubation to allow probe internalization as usual,
samples of labeled macrophages taken at various times were
incubated for 5 min with dithionite at room temperature to allow
internalization of the reducing agent into the lumen of endocytic
vesicles. During this secondary incubation, any probe remaining in
the medium or outer leaflet will be reduced to the nonfluorescent
form. In addition, reducing agent in the lumen of endocytic
vesicles will enter the endocytic pathway and when these vesicles
fuse with early endosomes, dithionite will come into contact with
previously endocytosed probe which is still restricted to the
(lumenal) leaflet. This process could reduce fluorescence from
probe molecules that have been sequestered by endocytosis. To
test whether this approach makes it possible to measure head-
group-specific transbilayer transport of phospholipids, the protocol
was used to compare the internalization of PC and PS in
macrophages. As shown in Figure 7, the assay revealed the
standard aminophospholipid translocase pattern of rapid PS
internalization and much slower PC internalization, comparable
to that seen in the control S cells in the same experiment. As with
other cell types, the macrophage translocase activity is unaffected
by disabling ABCA1. In this case, the rate of internalization of PC
Figure 6. Identification and annexin V staining of macrophages in peritoneal lavage from wildtype or ABCA1
2/2 mice. Cells from peritoneal
lavage were stained with mAb F4/80 (or isotype control mAb) or with annexin V on ice and examined by flow cytometry at room temperature. A,
forward (FS) vs side (SS) light scatter plot, with cells having typical macrophage light scatter characteristics in the M gate and Asmall@ cells in the S
gate. B, median fluorescence intensity of cells in the M gate (black) or S gate (grey) following staining with mAb F4/80 or isotype control mAb. C&D,
annexin V staining, in the presence (thin line) or absence (thick line) of Ca
2+, of cells in the M gate from wildtype (C)o rABCA1
2/2 (D) mice.
doi:10.1371/journal.pone.0000729.g006
ABCA1 in Phospholipid Dynamics
PLoS ONE | www.plosone.org 8 August 2007 | Issue 8 | e729by macrophages is measurable compared to no measurable
transport in the control S subpopulation. Uptake of PC by
macrophages includes both probe taken up by transport across the
bilayer, and probe taken up by endocytosis but not reduced by
internalized dithionite. This rate therefore defines an upper limit
for the background of nonspecific endocytic uptake of probe still in
the external leaflet but not reduced during the secondary
dithionite incubation.
By using this protocol to load cells with NBD-PS, the rate of PS
externalization by macrophages from wildtype and ABCA1
2/2
mice could be measured. As shown in Figure 8, the basal rate of
PS externalization is faster in macrophages (M region cells) than in
non-macrophages (S region cells) measured in the same popula-
tion. The rate for macrophages is comparable to that measured for
lymphocytes, for example (see Fig 5, above). More importantly,
the rate is similar whether macrophages are from wildtype or
ABCA1
2/2 mice, indicating that this form of outward transbilayer
PS movement is independent of ABCA1.
Whether the ablation of ABCA1 disables scramblase-mediated
lipid movement in macrophages could be tested by either activating
thescramblasewithCa
2+orbyusingapoptoticmacrophages.Dueto
the complexity of the light scatter distribution of the peritoneal
lavage preparation, the apoptotic macrophage population could not
be uniquely identified for separate analysis. Therefore, the
continuous annexin V binding assay described above was used to
measure Ca
2+-induced externalization of PS by macrophages. As
showninFigure9,elevationofcytosolicCa
2+inducedtheimmediate
appearance of additional PS on the macrophage surface; in contrast,
scramblase in the non-macrophage cells in the S region could not be
activated by Ca
2+, much as was observed in fibroblasts (Fig 3A).
Importantly, as was shown with the lymphocytes above, the
scramblase in macrophages also showed no defect, either in
activation or rate of PS appearance, when cells from ABCA1
2/2
mice were compared with wildtype. These results indicate that
ABCA1 is not a macrophage-specific form of the scramblase.
Combined with the absence of an ABCA1 requirement for
uninduced basal PS externalization, these results show that ABCA1
does not contribute to any measurable mechanism for PS
externalization in macrophages.
Given the absence of detectable reductions in transbilayer lipid
movements correlated with the deletion of ABCA1 in either
elicited peritoneal macrophages or their potential apoptotic targets
(see Table 1 for complete summary), whether a defect in apoptotic
cell recognition could be detected when ABCA1 was disabled in
either the recognizing macrophage, the apoptotic target, or both,
was examined. For this purpose, a standard phagocytosis assay was
used in which an excess of target apoptotic thymocytes were
presented to elicited macrophages immobilized on glass coverslips.
The number of engulfed target cells was then measured at 30 min
when the rate of target cell uptake is linear, so that the assay
measures the rate of recognition and engulfment [30]. As shown in
Figure 10A and B, dexamethasone induction of apoptosis in the
Figure 7. Internalization (translocation) of NBD-labeled phospholi-
pids by peritoneal macrophages from wildtype and ABCA1
2/2 mice.
The outer leaflet of the plasma membrane of macrophages from
wildtype (diamonds) or ABCA1
2/2 (squares) mice was labeled with NBD-
PC (open symbols) or NBD-PS (closed symbols). At various times
samples were removed into dithionate to reduce outer leaflet probe
and after 5 min remaining inner leaflet probe was measured by flow
cytometry at room temperature and expressed as percent transported.
Cells from wildtype (triangles) and ABCA1
2/2 (circles) mice in the S gate
in Figure 6 are shown for comparison.
doi:10.1371/journal.pone.0000729.g007
Figure 8. Basal NBD-PS externalization in peritoneal macrophages from wildtype or ABCA1
2/2 mice. Macrophages (squares) or cells in the S gate
in Figure 6 (circles) from wildtype (filled symbols) or ABCA1
2/2 (open symbols) mice were allowed to internalize NBD-PS, dithionite was added to
reduce and render non-fluorescent externalized NBD-PS, and cellular fluorescence (unexternalized NBD-PS) was measured continuously over time (A).
Rate constants derived by simple exponential fit to the data for macrophages (black) and gated S cells (grey) are compared in (B).
doi:10.1371/journal.pone.0000729.g008
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which wildtype thymocytes are engulfed by wildtype macrophages;
freshly isolated thymocytes spontaneously develop some apoptotic
cells, explaining the presence of some uptake using uninduced cells
as targets. The rate of engulfment is not reduced when either the
target cells, the macrophages, or both are derived from ABCA1
2/2
mice, indicating that this rate is not sensitive to the presence of
ABCA1 in this system. A comparable experiment was not possible
for the human system because Tangier and normal macrophages
were not readily available. However, EBV-transformed normal
and Tangier B lymphocytes were used as targets for wild-type
macrophages of the J774 mouse cell line. As shown in Figure 10C,
phagocytosis of apoptotic cells was not sensitive to the ABCA1
gene in the apoptotic target cells. Recognition and engulfment of
apoptotic cells in this system is dependent on PS expression, as
shown by the sensitivity of the engulfment to masking PS with
annexin V (Figure 10C).
Recognition and engulfment of target apoptotic cells is facilitated
by the presence of annexins I and II, on the surface of macrophages
[24]. It has been reported that ABCA1 is required for the export of
annexin I from cells [31]. Therefore, whether the presence or
absence of ABCA1 in mouse macrophages had any effect on the
display of annexin I and II on the macrophage surface was
examined.AsshowninFigure11,bothannexin Iand annexinIIcan
be readily detected by monoclonal antibodies on the surface of
elicited peritoneal macrophages. Their expression on cells from
ABCA1
2/2mice(Fig11B)wascomparabletoexpressiononwildtype
cells (Fig 11A), indicating that the presence of annexins I or II on the
macrophage surface is not dependent on ABCA1.
DISCUSSION
A major advance in our understanding of cholesterol transport was
the discovery that a defect in ABCA1 blocks the efflux of
cholesterol and phospholipids from cells to apoA1 to form
circulating HDL [1,2,32–34]. By itself, this discovery did not
identify the mechanism by which the ABCA1 protein facilitates
transfer of cholesterol to HDL, but good evidence suggests that it
acts upstream of actual transfer of cholesterol from the cell. One
proposal is that ABCA1 serves as a site for apoA1 to bind or dock
on the cell surface [28,35]. However, ABCA1 also facililitates
cholesterol transfer to artificial amphipathic helical peptides, even
those comprised of D-amino acids [36]; if providing a binding site
is the important function of ABCA1, there cannot be stereospec-
ificity for the ligands bound. Moreover, this proposal by itself fails
to explain why the ATPase activity of the protein is required for
ABCA1 function in the pathway [37]
Another proposal consistent with the involvement of ABCA1
early in the pathway forming HDL is that ABCA1 facilitates
phospholipid, rather than cholesterol, transfer to newly synthe-
sized, lipid-poor apoA1 to form a nascent HDL complex capable
of accepting cholesterol [38–40]. Once this phospholipid transfer
step has been completed, phospholipid-containing apoA1 particles
would then accept cholesterol from cells without any further
Figure 9. Ca
2+-activated endogenous PS externalization in peritoneal
macrophages from wildtype or ABCA1
2/2 mice measured by
continuous annexinV binding assay. Macrophages (squares) or cells
in the S gate in Figure 6 (circles) from wildtype (filled symbols) or
ABCA1
2/2 (open symbols) mice were treated with Ca
2+ and Ca
2+
ionophore, and cellular fluorescence measured continuously over time
at room temperature.
doi:10.1371/journal.pone.0000729.g009
Figure 10. Phagocytosis of apoptotic targets by wildtype or ABCA1
2/
2 macrophages. A&B, phagocytosis of non-apoptotic or apoptotic
thymocytes from wildtype (black) or ABCA1
2/2 (gray) mice by
peritoneal macrophages from wildtype (A) or ABCA1
2/2 (B) mice. C,
phagocytosis of camptothecin-induced apoptotic EBV-transformed
normal (black) or Tangier (gray) human B lymphocytes, either untreated
or pre-treated with 10 mM Annexin V, then washed prior to pre-
sentation to mouse J774 macrophages. Error bars represent the
standard error of 3 replicates.
doi:10.1371/journal.pone.0000729.g010
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interacts in some way with phospholipids, an attractive idea
because it might explain how ABCA1 could be required for
another function, also dependent on phospholipid interaction,
namely the engulfment of apoptotic cells. In particular, ABCA1
has been proposed as the mammalian functional homolog of ced-
7, an ABC protein required for clearance of apoptotic cells in C.
elegans. The requirement for ced-7 function in both apoptotic
target and phagocyte in nematodes [12] and the requirement for
PS exposure in both target and phagocyte in mammals [17,18,20]
suggests that the ced-7 homolog, ABCA1, might somehow
contribute to the transbilayer phospholipid movements that result
in PS exposure.
An understanding of the activities that control the transbilayer
distribution of PS is required to properly evaluate whether ABCA1
might be involved. Ordinarily, PS is confined to the inner leaflet of
mammalian plasma membranes by ATP-dependent inward
transport catalyzed by a subfamily IV P-type ATPase, the
aminophospholipid translocase [13,14]. It is conceivable that
apoA1 loading, like recognition of apoptotic cells, is sensitive to
this lipid arrangement, although perhaps not to the resulting
appearance of PS on the surface [41] . ABCA1 might modulate
this arrangement directly by regulating the activity of the
aminophospholipid translocase or indirectly, for instance, by
ensuring proper localization of the translocase at the plasma
membrane. However, the results presented in Figures 2 and 7 rule
out these possibilities by showing that the presence or absence of
ABCA1 has no effect on aminophospholipid transport activity.
PS comes to the cell surface in several physiological situations in
addition to apoptosis, including upon platelet activation [42] and
prior to myoblast fusion [43]. In apoptotic cells and platelets, the
appearance of PS on the cell surface is a consequence of two events
[15,44]. As might be expected, one is the downregulation of the
aminophospholipid translocase. The other is the upregulation of
the scramblase, which facilitates transbilayer movements of PS to
the cell surface. The properties of the scramblase in both cell types
is the same (Fig 1): all types of phospholipids are moved at identical
rates in both directions across the bilayer [21,45]. The studies with
ABCA1-deficient mouse and human cells presented here collec-
tively demonstrate that ABCA1 is not the (long-sought) scramblase
activity itself in lymphocytes, fibroblasts, HeLa cells, or macro-
phages.
If not the scramblase itself, ABCA1 could still be involved in
activation of the scramblase. Studies of cells from patients with
a rare clotting disorder, Scott syndrome, suggest that two different
activation pathways (Ca
2+-dependent and apoptotic, Ca
2+-in-
dependent) converge on a common scramblase enzyme. As
summarized in Figure 1, ABCA1 could be a protein involved in
one of these two activation pathways. In platelets and other
hematopoietic cells, including lymphocytes, scramblase can be
activated naturally or artificially by a Ca
2+-dependent pathway
that is disrupted by the Scott mutation. It was recently reported
that there is a single missense mutation in the ABCA1 gene of
a Scott patient and that transfection of wild-type ABCA1 into
lymphocytes from the patient restored Ca
2+-dependent activation
of the scramblase [46]. These results suggested that reduced
ABCA1 activity might result in a failure of PS exposure like that
observed in the Scott syndrome. As shown here, however, this
inference is incorrect: PS exposure by the scramblase is activated
by Ca
2+ equally efficiently whether or not cells contain a functional
ABCA1 gene (Figures 3 and 9). Similarly, it has been reported that
scramblase activation by ionophore and Ca
2+ is negligible in
fibroblasts from ABCA1
2/2 mice [7] As confirmed here, human
fibroblasts from Tangier patients do not activate the scramblase
upon treatment with ionophore and Ca
2+; however, this
phenotype is also observed in wild type fibroblasts, suggesting
that the ability to activate the scramblase by elevation of
cytoplasmic Ca
2+ may only be prominent in the hematopoietic
lineage. In apoptotic cells, including lymphocytes, scramblase is
activated by a Ca
2+-independent mechanism which is unaffected
by the Scott mutation. As shown in Figure 4, the absence of
ABCA1 does not affect PS exposure via this apoptotic activation
pathway, either.
A third possibility for involvement of ABCA1 in PS exposure,
shown in Figure 1, is that ABCA1, independent of the scramblase,
actively transports PS, and not other lipids, from the inner to the
outer leaflet of the plasma membrane. An activity of this sort was
first proposed to explain PS exposure in activated platelets [47],
but high resolution analysis of lipid movements in activated
platelets failed to reveal any evidence for PS-specific externaliza-
tion over and above the scramblase-mediated movement [45].
More recently, analyses of movements of spin-labeled PC and PS
analogs were also interpreted as evidence for an outward PS-
specific transport in mouse red blood cells treated with Ca
2+ and
ionophore [7], conditions known to activate the scramblase in
human red blood cells [48]. In these experiments, the induction of
rapid internalization of PC, characteristic of the scramblase
activity, was unaffected by knockout of the ABCA1 gene. The
behavior of the PS probe, however, was more complex. In red
blood cells from wild type mice, externalization of labeled PS was
slow and only 24% of it moved from the inner to the outer
membrane leaflet. In ABCA1
2/2 mice, externalization was
similarly slow, and only 10% of internalized probe was
externalized. On the basis of these findings, the investigators
concluded that Apart of PS externalization in the presence of
cytosolic Ca
2+ may be associated with ABCA1-dependent selective
outward transport@. This model suggests that PS externalization
results from both non-specific scramblase and PS-specific ABCA1
activity, and that when the latter is compromised, the rate of
externalization of PS should be reduced to the rate of scramblase-
mediated movement alone.
Figure 11. Binding of anti-annexin mAbs to peritoneal macrophages
from wildtype or ABCA1
2/2 mice. Macrophages from wildtype (A) or
ABCA1
2/2 (B) mice were stained with anti-annexin I, II or mouse IgG1
isotype control mAbs and analyzed by flow cytometry.
doi:10.1371/journal.pone.0000729.g011
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previous studies of lipid movements in ionophore treated human
red blood cells [48]. In these earlier studies with fluorescent
probes, scramblase activation resulted in PS movement as rapid,
and as extensive, as PC movement. Similar results were obtained
in studies of the scramblase activity in platelets [45] and in
lymphoid cells [22] using both fluorescent phospholipid analogs
and continuous annexin V binding assays of endogenous PS
movement. The failure of Hamon et al to observe PS equilibration
in normal controls makes it difficult to interpret their findings in
ABCA1
2/2 cells. The measurements of PS externalization rates
reported here fail to confirm that ABCA1 deletion reduces the rate
of PS externalization. Because ABCA1 ablation has no effect on
the PS externalization rate in lymphocytes or macrophages
activated by Ca
2+ and ionophore, it is unlikely that ABCA1
catalyzes PS-specific externalization depicted as a possibility in
Figure 1.
These findings are reassuring in one way, because an activity
that actively exports one major phospholipid population from one
leaflet to the other, when activated, would pose a difficult problem
for the maintenance of membrane integrity. Although PS
comprises only approximately 10% of plasma membrane
phospholipid, even a simple equilibration of only this lipid
between the two leaflets (from 100% inner to 50/50, inner/outer)
would produce a 10% difference in the surface areas of the two
leaflets, an unlikely event given that membranes cannot tolerate
a difference of more than 1–2% in the surface area of the two
leaflets. Active transport of all PS to the cell surface would be twice
as disruptive. Indeed, this potentially disruptive effect of lipid
movement may explain why the scramblase activity is non-specific
for phospholipid headgroup. Although its function may be to bring
PS to the cell surface, its nonspecificity provides an automatic
compensation mechanism which dissipates any disparity in leaflet
surface area as fast as it arises.
Because ABCA1 is prominently expressed in macrophages, it
might seem likely, a priori, that the characteristics and function of
this cell type would be affected by ABCA1 inactivation. The
elevated level of annexin V binding to normal macrophages
suggests that transbilayer lipid movements are altered in these
cells, and it has been reported that annexin V binding to
macrophages from ABCA1
2/2 mice is reduced [7], although the
data were not presented. The development of methods to measure
lipid movements in macrophages reported here provides the first
opportunity to actually examine this dynamic phenomenon in
these membrane-active cells, rather than to measure just static
levels of exposed PS using annexin V. The results presented here
provide evidence that many of the transbilayer lipid movements
seen in other hematopoietic cells are present in macrophages as
well, including both translocase and Ca
2+-induced scramblase
activity. However, the assays also indicate that none of these
transbilayer lipid movements, nor the elevated level of basal PS
exposure measured by annexin V binding, requires the presence of
ABCA1 in macrophages (Figures 6–9). In addition, a reduction in
Ca
2+-dependent annexin V binding by the F4/80-positive cells in
the cell population could not be detected. These results indicate
that ABCA1 is not responsible for readily-measurable lipid
transport activity in macrophages, including catalysis of PS-
specific externalization. In keeping with these observations, elicited
peritoneal macrophages from ABCA1
2/2 mice were no less
effective than wild type cells as phagocytes of apoptotic thymocytes
in a controlled, in vitro assay. Although these results do not rule out
a role for ABCA1 in the recognition of apoptotic cells, they do
indicate that the contribution of ABCA1 to engulfment is
quantitatively much less significant than that of the many other
molecules identified by these in vitro assays, such as CD14 [49,50],
integrins [30,51], or annexin I [24].
A potential positive effect of ABCA1 activity was suggested by
reports that introduction of ABCA1 into HeLa cells specifically
activated spontaneous externalization of previously internalized
NBD-PS [52] In the higher resolution experiments described here
with an independent line of ABCA1-transfected HeLa cells, no
difference in externalization was observed. In addition, no
reduction in the rate of basal PS efflux was observed in primary
fibroblasts, macrophages, or lymphocytes lacking the ABCA1
2/2
gene. Some experiments have suggested that ABCA1 is essential
for loading of phospholipid onto apoA1 to convert it to a form
capable of taking up cholesterol [40,53]. The experiments shown
here demonstrate that the function provided by ABCA1 is not PS
externalization stimulated by the presence of apoA1, at least on
any large scale.
Understanding the function of ABCA1 in the efflux of
cholesterol to HDL is also a persistent puzzle. The possibility that
a phospholipid transport function was a key to solving this puzzle
was a welcome unifying idea, because of the clear and defined
importance of phospholipid transport in the process of clearance of
apoptotic cells. The molecules that are responsible for mediating
and regulating the transbilayer transport of PS required for
recognition of apoptotic cells (among other functions) have resisted
identification, and the possibility that ABCA1 is one of those
molecules was an important potential implication of this unifying
idea. The results presented here indicate that this possibility is not
realized-ABCA1 plays no readily identifiable role as translocase,
scramblase, or regulator of either of those molecules in either the
Ca
2+-stimulated or apoptosis-stimulated pathways in hematopoi-
etic or fibroblast cells. These results do not rule out a role for
ABCA1 in phospholipid loading of apoA1. Indeed, recent studies
suggest that this enzyme plays a role in changing the conformation
of apoA1, and loading as many as two PC molecules on the
rearranged protein [40]. The loading of PC molecules in those
studies is unlikely to involve transbilayer lipid movement, since PC
is normally concentrated in the external leaflet of the plasma
membrane, and the number of PC molecules loaded is small
compared to the number of PC molecules present in the outer
leaflet. Whether ABCA1 might function in a similar fashion during
the process of apoptotic cell recognition will be an interesting
possibility for future consideration.
MATERIALS AND METHODS
Reagents
ApoA-1(A-0722), propidium iodide (PI), RPMI-1640 and a-MEM
medium, fatty acid free bovine serum albumin (BSA, A-6003),
dexamethasone, purified mouse IgG1 (clone MOPC 21) mAb
isotype control, fluorescein isothiocyanate (FITC)-conjugated goat
anti-mouse IgG and unconjugated goat IgG were purchased from
Sigma-Aldrich (St. Louis, MO). Glibenclamide/Glyburide was
from Research Biochemicals International (Natick, MA). Camp-
tothecin was from MP Biomedicals (Irvine, CA). Ca
2+ ionophore
A23187 was from Calbiochem (EMD Biosciences, Inc., San
Diego, CA). Diff-Quik staining reagents were from Baxter (Miami,
FL). Hygromycin B, geneticin selective antibiotic (G418) and
trypsin-EDTA (0.25% trypsin, 1mM EDTA) were from Gibco
(InVitrogen, Carlsbad, CA). FITC-conjugated rat anti-mouse F4/
80 mAb (clone CI:A3-1, IgG2b) and FITC-conjugated rat mAb
IgG2b (clone LO-DNP-11) isotype control were purchased from
Serotec (Raleigh, NC). Mouse anti-annexin I mAb (clone 29,
isotype IgG1) generated against bovine annexin I, and mouse anti-
annexin II mAb (clone 5, isotype IgG1) generated against bovine
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(Lexington, KY). 1-oleoyl-2-[6[(7-nitro-2,1,3-benzoxadiazol-4-
yl)amino] caproyl]-sn-glycero-3-phosphocholine (NBD-PC) and
the corresponding phosphatidylserine analog (NBD-PS) were
purchased from Avanti Polar Lipids (Alabaster, AL). Fluorescei-
nated annexin V was either FITC-conjugated annexin V
purchased from Molecular Probes (Eugene, OR) or 5,6-carboxy-
fluorescein (5,6-FAM)-derivatized recombinant annexin V (see
below).
Preparation of fluorescein-derivatized annexin V
4 mg of recombinant human annexin V, purified as described
previously [20], in 2 mL of Tris buffer was dialyzed overnight at
4uC against 200 mM sodium bicarbonate, pH 8.5, to which
0.2 mg of 5,6 FAM-succinimide (AnaSpec, Inc., San Jose, CA) was
then added from a 10 mg/ml stock in DMF. After mixing for 1 hr
at 25uC, protected from light, the reaction mixture was dialyzed
extensively in the dark against 25 mM HEPES, pH 7.4, 140 mM
NaCl, 1 mM EDTA before dilution to 45 mg of protein/ml.
Bovine serum albumin (BSA) and sodium azide were added to
10 mg/ml and 0.01%, respectively.
Cell culture
HeLa (Tet-off) cells obtained from Clontech (Mt. View, CA) and
co-transfected with pTRE2-ABCA1-GFP and pTK-Hyg (to
provide a selectable marker) or transfected with pTK-Hyg alone
(control) , human EBV-transformed B lymphocyte lines derived
from a normal individual (ARB) and a Tangier disease patient
(ARA), and normal human fibroblasts (line 1947) and human
fibroblasts derived from a Tangier disease patient have been
previously described [25]. ABCA1 genotypes of EBV-transformed
B lymphocytes were verified by standard PCR [32]. HeLa cells
were maintained in a-MEM medium supplemented with 10% fetal
bovine serum (FBS), 50 U/ml of penicillin, 50 mg/ml of
streptomycin, 200 mM hygromycin B, and 200 mM G418, at
37uC and 5% CO2. EBV-transformed B lymphocyte lines were
maintained in RPMI 1640 medium plus 10% FBS , 50 U/ml of
penicillin, and 50 mg/ml of streptomycin at 37uC and 5% CO2.
Fibroblast cell lines were grown in a-MEM medium with the same
additives at 37uC and 5% CO2 and were maintained at a low
passage number. For cell passage and analysis in suspension, cells
were removed from monolayer culture by a 30 sec exposure to
trypsin-EDTA. Jurkat cells and the J774A.1 mouse macrophage
cell line (American Type Culture Collection) were maintained in
RPMI 1640 medium supplemented with 10% FBS, 100 U/ml of
penicillin and 100 mg/ml of streptomycin at 37uC and 5% CO2.
ABCA1 null mutant mice
A heterozygous pair of strain DBA/1-Abca1
tm1Jdm (stock number
003897) mice was purchased from the Jackson Laboratory (Bar
Harbor, ME) and maintained on regular chow and water ad
libitum, in accordance with the institutional guidelines of the
Animal Care and Use Committee. A breeding colony derived
from this original pair was the source of ABCA1 homozygous
(2/2), heterozygous (+/2), and wildtype (+/+) mice used in this
study. Mice were genotyped as described (http://jaxmice.jax.org/
pub-cgi/protocols/protocols.sh?objtype=protocol&protoco-
l_id=465).
Primary mouse macrophages
Inflammatory macrophages were elicited in the peritoneal cavity
of 6–8 wk old mice by intraperitoneal injection of 2 ml of 3%
Brewer=s thioglycollate. Cells were harvested 5–6 days later by
peritoneal lavage using 10 ml of ice-cold RPMI 1640 medium.
The collected cells were washed in RPMI 1640 medium and
suspended at a concentration of 3610
6 cells/ml in RPMI 1640
medium containing 10% FBS. For enrichment of macrophages for
phagocytosis assays, cell suspensions (150 mL) were pipetted onto
18 mm bicarbonate-treated glass coverslips placed in the wells of
a 12-well culture plate. After 2 h at 37uC and 5% CO2,
nonadherent cells were removed by aspiration. Then, 1 ml of
fresh RPMI 1640 medium containing 10% FBS was added to each
well and cultures were incubated overnight at 37uC and 5% CO2
before phagocytosis assays.
Apoptotic targets
Thymuses were removed from 6–8 wk-old mice and dissociated in
RPMI 1640 medium. Following centrifugation, cells were
resuspended at 4–5610
6 cells/ml in RPMI 1640 medium. To
produce apoptotic targets, 10
26 M dexamethasone was added and
cells were incubated for 4–6 h at 37uC and 5% CO2. EBV-
transformed B lymphocyte lines, maintained in RPMI 1640
medium plus 10% FBS, were treated with 4mg/ml of camptothe-
cin for 6 h to induce apoptosis.
mAb staining
10
6 cells from peritoneal lavages were preincubated in 50 uL of
PBS containing 1% FBS and goat IgG at 1.4 mg/ml for 5 min on
ice. FITC-anti mouse F4/80 mAb or FITC-IgG2b isotype control
mAb was then added to the suspension at a final concentration of
10 mg/ml. Staining with anti-annexin I, anti-annexin II, and IgG1
isotype control antibodies was as previously described [24].
Annexin V staining
FITC- or 5,6 FAM-annexin V (0.5 uL) was added to 2610
5 EBV-
transformed B lymphocytes or 5610
5 peritoneal lavage cells in 50
mL of annexin V binding buffer (ABB,10 mM HEPES, pH 7.4,
140 mM NaCl, 2 mM CaCl2) or ABB without Ca
2+. After 5 min
on ice, the volume was brought to 500 uL by addition of the same
buffer. PI was added to a final concentration of 10 ug/ml
immediately before flow cytometric analysis.
Flow cytometry
Cells (10
4) were analyzed at room temperature using an EPICS-
XL-MCL flow cytometer (Coulter Electronics, Hialeah, FL) with
excitation at 488 nm. FITC (or FAM) staining was monitored at
525 nm. PI fluorescence was monitored at 610 nm and PI-positive
cells were gated out of all profiles. Forward and side light scatter
properties were used to gate for morphologically normal
lymphocytes, macrophages and fibroblasts, which include both
non-apoptotic and early apoptotic cells. All experiments were
repeated at least once, and, in most cases, many times. For
comparisons, samples of different genotype were always examined
in parallel, using the same reagents and cytometer settings, to
eliminate differences resulting from day-to-day variations in
instrument performance, reagent stability, etc.
Phagocytosis assay
All assays were performed in triplicate. Thymocytes or camp-
tothecin-treated EBV-transformed B lymphocytes (1.5610
6)i n
150 mL of ABB were overlaid onto cultures of either elicited
peritoneal macrophages or J774.1 cells prepared and washed as
previously described [20]. In some experiments, EBV-transformed
B lymphocytes were incubated for 15 min in 10 mM annexin V in
ABB prior to washing and resuspending in 150 mL ABB and
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37uC and 5% CO2, coverslips were washed vigorously with
phosphate buffered saline (PBS), fixed in 1.8% formaldehyde for
5 min, and then submerged in PBS until counted. Just prior to
counting, fixed cells on coverslips were stained with Diff-Quik and
then phagocytosed cells enumerated as described in detail
previously [30]
Continuous annexin V binding assay for PS
externalization
Briefly, 10
5 cells were suspended in 750 mL of ABB containing 0.7
mg/ml of PI and 1-2 mL of FITC- or FAM-annexin V. Ca
2+
ionophore A23187 was added to a final concentration of 2-7 mM
and the cell suspension was then sampled continuously in the flow
cytometer, as previously described [22].
NBD-phospholipid translocase assays
10
5 HeLa cells, fibroblasts or B lymphocytes, washed free of
serum, were resuspended in 800 mL of HEPES buffer (10 mM
HEPES, pH 7.4, 150 mM NaCl) and PI was added to a final
concentration of 1.2 mg/ml. 6 mL of NBD-PS or NBD-PC, dried
from a concentrated chloroform stock and resuspended in HEPES
buffer to 30 mM, was then added, and 50 mL samples were taken at
indicated time intervals and diluted into 200 mL of HEPES buffer
(pre-cooled on ice) with 1% fatty acid-free BSA, to extract label
remaining in the outer leaflet of the membrane, or without BSA, to
measure total fluorescence. After 2 min for extraction, samples
were introduced into the flow cytometer and fluorescence
measured as previously described [22]. To reduce noise in-
troduced by the presence of small numbers of very bright cells in
the population, median fluorescence was used as the measure of
population fluorescence intensities. For mouse macrophages, 10
5
peritoneal exudate cells were resuspended in 600 mL of ABB and
PI was added as above. NBD-PS or NBD-PC was added as
described above but in order to ameliorate the effects of probe
uptake by endocytosis, samples (50 mL) were added to 200 mLo f
Hanks buffer, and 2.5 mL of a freshly prepared 1.0 M stock
solution of sodium dithionite in 1.0 M Tris-HCl was added 5 min
before measurement by flow cytometry as described [22].
NBD-PS externalization assay
A continuous flow cytometric assay, similar to a spectro-fluoro-
metric assay described previously for platelets [45]and cultured
cells [22], was used to monitor the outward movement of NBD-
PS. Cells (10
5), suspended in 750 mL of ABB or medium without
serum, were first preloaded with NBD-PS by adding 2 mL (for
HeLa , macrophages and lymphocytes) or 10mL (for fibroblasts) of
a3 0mM stock of NBD-PS (prepared as described above) followed
by incubation for 3 min, to minimize the level of probe
internalized by nonspecific endocytosis (macrophages) or 10 min
(lymphocytes, Hela and fibroblasts). A 10 mL aliquot of a 1M
solution of sodium dithionite (freshly prepared as described above)
was then added and the cell suspension was analyzed continuously
by flow cytometry for 15 min at room temperature to measure the
fraction of internalized NBD-PS remaining inside the cell. For
measurements of the effect of apoA-1 on PS externalization in B
lymphocytes and fibroblasts, 10 mg/ml of apoA-1 was added and
incubation was continued for 5 min, prior to the addition of
sodium dithionite. Measured rates were routinely tested for
sensitivity to the concentration of added dithionite as a control
for membrane permeability to dithionite ions.
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